ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
派格生物醫藥-B
10.200
-0.640
-5.90%
手動刷新
成交量:
79.96萬
成交額:
826.24萬
市值:
39.37億
市盈率:
-12.07
高:
10.840
開:
10.840
低:
10.000
收:
10.840
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
派格生物醫藥-B
交易所:
SEHK
成立時間:
2008
員工人數:
53
公司地址:
Room 606,Building 1,Haozhang Tower,Gongshu District,Hangzhou,Zhejiang Province,China
官網:
http://www.pegbio.com
郵編:
215123
電話:
86 512 6295 6128
傳真:
86 512 6295 6130
簡介:
派格生物醫藥(蘇州)有限公司是一家專註於創新藥物開發的生物醫藥公司,2008年5月成立於蘇州工業園區生物產業園(bioBay)。基於對慢病發病機制、慢病患者治療需求以及慢病市場競爭的深刻理解,公司聚焦新作用機制、具有潛在優勢的靶點,通過HECTORTM核心技術體系自主開發成藥性高、療效和安全性良好的藥物分子,廣泛覆蓋2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛風以及阿爾茲海默症等患者數量大、用藥周期長的多種慢性疾病,並逐漸延伸到其他慢病領域,包括阿片類藥物引起的便秘、先天性高胰島素血症等。
董事
名稱
職位
Michael MIN XU
董事長,執行董事,戰略發展委員會主席,提名委員會委員
王小軍
執行董事,薪酬與考核委員會委員
ZHANG JIANCUN
獨立非執行董事,薪酬與考核委員會主席,提名委員會主席
陳秧秧
獨立非執行董事,審計委員會委員
范新鵬
獨立非執行董事,薪酬與考核委員會委員,提名委員會委員,審計委員會主席
ZHOU Xiangjun
非執行董事,戰略發展委員會委員,審計委員會委員
徐宇虹
非執行董事,戰略發展委員會委員
翟婷
非執行董事
李宏凱
非執行董事
王夢嬌
監事會主席,職工代表監事
孔勇軍
監事
李東
監事
股東
名稱
職位
Michael MIN XU
總經理
王小軍
財務總監
黃一峰
董事會秘書,聯席公司秘書,董事會助理
陳婉梅
聯席公司秘書
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02565/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物醫藥-B","latestPrice":10.2,"timestamp":1748592503030,"preClose":10.84,"halted":0,"volume":799600,"delay":0,"floatShares":279164339,"shares":385955532,"eps":-0.8453952749227656,"marketStatus":"休市中","change":-0.64,"latestTime":"05-30 16:08:23","open":10.84,"high":10.84,"low":10,"amount":8262390,"amplitude":0.077491,"askPrice":10.24,"askSize":12000,"bidPrice":10.2,"bidSize":21500,"shortable":0,"etf":0,"ttmEps":-0.8453952749227656,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748827800000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":10.84,"openAndCloseTimeList":[[1748568600000,1748577600000],[1748581200000,1748592000000]],"volumeRatio":0.15349667577010448,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":279164339,"roa":"-61.30%","roe":"-224.15%","lyrEps":-0.845395,"volumeRatio":0.15349667577010448,"shares":385955532,"dividePrice":0,"high":10.84,"amplitude":0.077491,"preClose":10.84,"low":10,"week52Low":10,"pbRate":"68.90","week52High":13.5,"institutionHeld":0,"latestPrice":10.2,"committee":0.283582,"eps":-0.8453952749227656,"divideRate":0,"volume":799600,"delay":0,"ttmEps":-0.8453952749227656,"open":10.84,"prevYearClose":15.6,"prevWeekClose":15.6,"prevMonthClose":10.2,"prevQuarterClose":15.6,"fiveDayClose":15.6,"twentyDayClose":15.6,"sixtyDayClose":15.6},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":61902235,"yearFounded":2008,"employeeNum":53,"address":"Room 606,Building 1,Haozhang Tower,Gongshu District,Hangzhou,Zhejiang Province,China","zipCode":"215123","officePhone":"86 512 6295 6128","officeFax":"86 512 6295 6130"},"stockCompanyDetail":{"websiteUrl":"http://www.pegbio.com","stockEarnings":[{"period":"1week","weight":-0.3462},{"period":"ytd","weight":-0.3462}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0529},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.199},{"period":"1year","weight":0.2775},{"period":"ytd","weight":0.161}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"派格生物醫藥(蘇州)有限公司是一家專註於創新藥物開發的生物醫藥公司,2008年5月成立於蘇州工業園區生物產業園(bioBay)。基於對慢病發病機制、慢病患者治療需求以及慢病市場競爭的深刻理解,公司聚焦新作用機制、具有潛在優勢的靶點,通過HECTORTM核心技術體系自主開發成藥性高、療效和安全性良好的藥物分子,廣泛覆蓋2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛風以及阿爾茲海默症等患者數量大、用藥周期長的多種慢性疾病,並逐漸延伸到其他慢病領域,包括阿片類藥物引起的便秘、先天性高胰島素血症等。","exchange":"SEHK","name":"派格生物醫藥-B","nameEN":"PEGBIO CO-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":{"directors":[{"name":"Michael MIN XU","position":"董事長,執行董事,戰略發展委員會主席,提名委員會委員"},{"name":"王小軍","position":"執行董事,薪酬與考核委員會委員"},{"name":"ZHANG JIANCUN","position":"獨立非執行董事,薪酬與考核委員會主席,提名委員會主席"},{"name":"陳秧秧","position":"獨立非執行董事,審計委員會委員"},{"name":"范新鵬","position":"獨立非執行董事,薪酬與考核委員會委員,提名委員會委員,審計委員會主席"},{"name":"ZHOU Xiangjun","position":"非執行董事,戰略發展委員會委員,審計委員會委員"},{"name":"徐宇虹","position":"非執行董事,戰略發展委員會委員"},{"name":"翟婷","position":"非執行董事"},{"name":"李宏凱","position":"非執行董事"},{"name":"王夢嬌","position":"監事會主席,職工代表監事"},{"name":"孔勇軍","position":"監事"},{"name":"李東","position":"監事"}],"executives":[{"name":"Michael MIN XU","position":"總經理"},{"name":"王小軍","position":"財務總監"},{"name":"黃一峰","position":"董事會秘書,聯席公司秘書,董事會助理"},{"name":"陳婉梅","position":"聯席公司秘書"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2025-05-30","current":-12.743079,"percent":1,"low":-19.497942,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"high":-12.743079,"avg":-14.696197,"sd":2.46554,"marketCap":3936746426},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426}],"updateTime":1748752396604}}}